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What are the best nutritional 
outcome measures? 
Helen White  
 
What is the value of nutritional 
outcome measurement? 
Clinical use of data Benchmarking and quality 
improvement 
Quality measure in contracts Pay for performance 
Patient choice Choosing high quality providers; 
informed treatment choices 
Resource allocation; productivity 
measures 
Allocate scarce resources more 
efficiently 
Tackling Health Inequalities Appropriate access for needs 
Regulation Assessing minimum standards 
National accounting Outcomes Frameworks and 
productivity 










Patient reported outcome 
Nutrition and 





 Evidence based 50th percentile cut-off value based on its 
association with lung function 
 Directly derived from data from the general population 
 Superior to Ht/age and Wt/age 
 More sensitive to changes in stature and age 
 More sensitive to changes in FEV1 than %IBW and had a stronger 
association to FEV1 than %IBW 
 Directly interchangeable with  z-scores 
 Forms a practical and sensitive measure for comparison and 
benchmarking 
 
 Weidemann et al 2007 German registry data confirmed  
 BMI as a more sensitive outcome measure 
 Close correlation of BMI percentile with wt/age                       

































≥ 50 3.5% 21.6% 2.7% 19.3% 
25 < 50 16.0% 27.2% 16.7% 25.9% 
< 25 39.3% 31.3% 38.2% 29.7% 
Konstan et al., 2014 
 1/5 of children with a BMI above the 50th centile 
had a height for age below the 10th centile 
 As did  1/4 with BMI between the 25th and 50th 
centile 
 
 Changes in US  - 1/3 centres changed by more than a tertile in 
rankings 
 2 of the best 5 centres on nutritional failure moved to the 
bottom tertile for below BMI goal 
 Identified that using a single outcome measure can be 
misleading and that BMI goal outcome measure should not 
be the sole basis for making treatment decisions and 
identifying the best centres against which to benchmark 
best practice. 
 Other indicators such as abnormal status of fat soluble 
vitamins should also be used 























Ahmed et al, 2004 (FFM) 10-16 
yrs 
7.6% girls 
10.7 % boys 
FEV1 (boys only) 







Williams et al, 2010 (FFM) 6-12 yrs 
 
Not associated with 
FEV1 
King et al, 2010 (FFM) Adults 14% 58% FEV1 










Fogarty et al, 2011 (LBM) Adults - FEV1 
Rochat et al, 1994 (LBM) Adults 66% - BMD 
Hollander et al,  2014 (FFM) Adults  60% 39% Survival post Tx 
Sheikh et al, 
2014 
High likelihood of 
normal lung 
function, targeting 
BMI z-score > 0 
 
Improved further, 




































50% of cases had a reduction in LTM 
White et al., 2014 
 Surrogate measures for nutritional outcomes 
for LTM 
 Handgrip strength 
 BIA 
 DEXA 
 Calcium  
 Vitamin D  
 Vitamin A 
 Vitamin K 
 
 All have target levels and norms specified by current 
guidance 
Carr et al. 1996 Aird et al. 2006 
Vitamin A associated with CRP 
inflammation (Greer et al, 2003), pulmonary exacerbation 
(Duggan et al, 1996; LaGrange et al, 2004 
McAuley et al, 2014 
Most studies have shown no association between 
Vitamin D and lung function 
 Achievement of  minimum of 110% EAR in 
pancreatic insufficiency 
 Studies that have examined energy intakes before 





 BMI z-score 
 BMI  
 
 
 Energy intake 
improved from 

































% energy intake change from baseline 
Steinkamp et al, 2000 
Powers et al, 2003 
Stark et al, 2009 
Skypala et al, 1998 
Kalnins et al, 2005 
Age Intake 
0-6 months 210mg 
7-12 months 270mg 
1-3 years 500mg 
4-8 years  800mg 
9-18 years 1300mg 
19-50years 1000mg 
>50 yrs 1200mg 




















26.7% 39.9% 29.8% 
Suggests that absorption is comparable to healthy children 
 
Lower gut pH in CF may enhance calcium absorption 
 











Clinical Care Guidelines 
for Cystic fibrosis - 
related diabetes 








Sputum glucose and 
glycaemic control in 
CFRD: a cross-sectional 
study (Sambeek et al, 
2015) 















Study Nutritional indicator Impact 
Abbott et al, 2007  Enteral tube feeding Poorer body image 
Rufenacht et al, 
2010  
Nutrition Counselling Improved nutrient 
intake and QoL 





physical function and 
body image 
Abbott et al., 
2015  
Decreased BMI Results in reduced 
body image HRQoL 
Validated measures CFQ-R (Age specific) and CFQoL 
 
FDA (USA) and NICE (UK) advocate use in evaluating new treatments 
 Digital era  
 Exploration, validation 
& capture of simple, 
global, patient  
reported outcome 
measures 







Applicable to Validated 
BMI 50th percentile  
Weight percentile 
Height percentile  
 
BMI 22  
BMI 23 















Minimum 110% EAR 
Calcium intake (target levels) 
All 
All children and adults 
Less robust 
Vitamin A ,D, E,K level of 
30ng/ml 




Diabetes  HbA1C <7.0%) Early stage 
PRO (M) measures  All  Yes 
PRE (M) measures All Early stage 
White et al, (2015) Variation in random capillary blood glucose and 
HbA1c as predictors of Cystic Fibrosis Related Diabetes (CFRD) 
Use of ‘real time’ data in outcome 
measurement 
 Practical, simple, validated 
 Agreed reporting of measures  
 Explain all aspects of nutritional delivery and 
outcome 
 Class mutation 
 Comorbidity 
 Socioeconomic status 





           Thank you 
